Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 8/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5841679 | 0.95 | PDK2 (0.43) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17678560 | 0.92 | PDK2 (0.42) | PDK2CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL17678567 | 0.91 | PDK2 (0.41) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17680057 | 0.91 | PDK2 (0.41) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL10018629 | 0.90 | PDK2 (0.40) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL13145407 | 0.90 | PDK2 (0.40) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL25750216 | 0.89 | PDK2 (0.41) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17678563 | 0.88 | PDK2 (0.39) | PDK2APEX1PGR | |
| SCHEMBL13658651 | 0.87 | PDK2 (0.40) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL28781068 | 0.87 | PDK2 (0.40) | PDK2KDM4EALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120104940-A1 | NOVEL COMPOUNDS FOR ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTRONIC DEVICE USING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2012-05-03 | — | — | US | disclosed |
| US-20120104940-A1 | NOVEL COMPOUNDS FOR ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTRONIC DEVICE USING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2012-05-03 | — | — | US | disclosed |
| WO-2010114243-A2 | NOVEL COMPOUNDS FOR ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTRONIC DEVICE USING THE SAME | DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120104940-A1 | NOVEL COMPOUNDS FOR ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTRONIC DEVICE USING THE SAME | OCIAD2, OCIAD1, SLCO4C1 | PDK2 2101/4885KDM4E 2701/4885ALDH1A1 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.